KATIE FAVREAU: Open Payments
NPI 1285270579 · LOWELL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 7 payments from 6 companies in 2025. Trend: 2023 $47 · 2024 $341 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $45 |
| Novo Nordisk Inc | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: CARVYKTI, Ozempic, AIRSUPRA, TRELEGY ELLIPTA, PREVNAR 20, RYBREVANT, GEMTESA.
Industry payments across MA — which companies pay providers there.
